These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 10726062
1. Hepatitis C virus in the transplant setting. Berenguer M, Wright TL. Antivir Ther; 1998; 3(Suppl 3):125-36. PubMed ID: 10726062 [Abstract] [Full Text] [Related]
2. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C. Abdelmalek MF, Firpi RJ, Soldevila-Pico C, Reed AI, Hemming AW, Liu C, Crawford JM, Davis GL, Nelson DR. Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857 [Abstract] [Full Text] [Related]
3. Chronic hepatitis C virus infection in renal transplant: treatment and outcome. Sharma RK, Bansal SB, Gupta A, Gulati S, Kumar A, Prasad N. Clin Transplant; 2006 Feb; 20(6):677-83. PubMed ID: 17100715 [Abstract] [Full Text] [Related]
4. Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonresponders to interferon. Di Bisceglie AM, Thompson J, Smith-Wilkaitis N, Brunt EM, Bacon BR. Hepatology; 2001 Mar; 33(3):704-7. PubMed ID: 11230751 [Abstract] [Full Text] [Related]
5. [Hepatitis C and liver transplantation]. Durand F. Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B82-90. PubMed ID: 12180312 [No Abstract] [Full Text] [Related]
6. Antiviral therapy for hepatitis C virus recurrence following liver transplantation: long-term results from a single center experience. Burra P, Targhetta S, Pevere S, Boninsegna S, Guido M, Canova D, Brolese A, Masier A, D'Aloiso C, Germani G, Tomat S, Fagiuoli S. Transplant Proc; 2006 May; 38(4):1127-30. PubMed ID: 16757285 [Abstract] [Full Text] [Related]
7. Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis. Roche B, Sebagh M, Canfora ML, Antonini T, Roque-Afonso AM, Delvart V, Saliba F, Duclos-Vallee JC, Castaing D, Samuel D. Liver Transpl; 2008 Dec; 14(12):1766-77. PubMed ID: 19025933 [Abstract] [Full Text] [Related]
8. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children. Czerwionka-Szaflarska M, Chrobot A, Szaflarska-Szczepanik A. Med Sci Monit; 2000 Dec; 6(5):964-70. PubMed ID: 11208439 [Abstract] [Full Text] [Related]
9. Prophylaxis and treatment of recurrent viral hepatitis after liver transplantation. Riediger C, Berberat PO, Sauer P, Gotthardt D, Weiss KH, Mehrabi A, Merle U, Stremmel W, Encke J. Nephrol Dial Transplant; 2007 Sep; 22 Suppl 8():viii37-viii46. PubMed ID: 17890261 [Abstract] [Full Text] [Related]
14. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Cacoub P, Lidove O, Maisonobe T, Duhaut P, Thibault V, Ghillani P, Myers RP, Leger JM, Servan J, Piette JC. Arthritis Rheum; 2002 Dec; 46(12):3317-26. PubMed ID: 12483738 [Abstract] [Full Text] [Related]
15. [The course of hepatitis C infection after liver transplantation]. Ołdakowska-Jedynak U, Paczek L. Pol Merkur Lekarski; 2005 Aug; 19(110):220-4. PubMed ID: 16245439 [Abstract] [Full Text] [Related]
17. Should patients with chronic hepatitis C infection be transplanted? Botero RC. Transplant Proc; 2004 Jun; 36(5):1449-54. PubMed ID: 15251356 [Abstract] [Full Text] [Related]
18. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load. Akuta N, Suzuki F, Sezaki H, Suzuki Y, Hosaka T, Someya T, Kobayashi M, Saitoh S, Watahiki S, Sato J, Kobayashi M, Arase Y, Ikeda K, Kumada H. J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715 [Abstract] [Full Text] [Related]